Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TXA127 for upper-limb sensorimotor recovery after ischemic stroke
MOH_2023-07-13_012815Phase 2Not yet recruiting
- Sponsor
- Constant Therapeutics LLC
- Start
- Jun 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing TXA127 with Placebo (2 arms). Planned start Jun 2023; status: not yet recruiting.
02
Drugs
angiotensin-(1-7)
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on MOH_2023-07-13_012815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2023-07-13_012815.